Misu T - Search Results

1

Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study.

Fujihara K, Kim HJ, Saida T, Misu T, Nagano Y, Totsuka N, Iizuka M, Kido S, Terata R, Okumura K, Hirota S, Cree BAC. Fujihara K, et al. Among authors: misu t. Mult Scler Relat Disord. 2023 Nov;79:104938. doi: 10.1016/j.msard.2023.104938. Epub 2023 Aug 20. Mult Scler Relat Disord. 2023. PMID: 37769428 Free article. Clinical Trial.

2

Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis.

Nakashima I, Fujihara K, Misu T, Okita N, Takase S, Itoyama Y. Nakashima I, et al. Among authors: misu t. J Neuroimmunol. 2000 Nov 1;111(1-2):64-7. doi: 10.1016/s0165-5728(00)00389-1. J Neuroimmunol. 2000. PMID: 11063822

3

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling.

Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y. Misu T, et al. J Neuroimmunol. 2001 Mar 1;114(1-2):207-12. doi: 10.1016/s0165-5728(00)00456-2. J Neuroimmunol. 2001. PMID: 11240033

4

[Epidemiology and clinical features of optic-spinal form multiple sclerosis in Japan].

Nakashima I, Fujihara K, Misu T, Itoyama Y. Nakashima I, et al. Among authors: misu t. No To Shinkei. 2001 Oct;53(10):911-7. No To Shinkei. 2001. PMID: 11725500 Review. Japanese. No abstract available.

5

Pure optic-spinal form of multiple sclerosis in Japan.

Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, Itoyama Y. Misu T, et al. Brain. 2002 Nov;125(Pt 11):2460-8. doi: 10.1093/brain/awf260. Brain. 2002. PMID: 12390972

6

A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands.

Nakashima I, Fujihara K, Misu T, Fujimori J, Sato S, Takase S, Itoyama Y. Nakashima I, et al. Among authors: misu t. Mult Scler. 2002 Dec;8(6):459-62. doi: 10.1191/1352458502ms831oa. Mult Scler. 2002. PMID: 12474983

7

[Pathogenesis of optic-spinal MS].

Fujihara K, Nakashima I, Misu T, Fujimori J, Feng J, Sato S, Miyazawa I, Itoyama Y. Fujihara K, et al. Among authors: misu t. Rinsho Shinkeigaku. 2002 Nov;42(11):1195-7. Rinsho Shinkeigaku. 2002. PMID: 12784704 Review. Japanese.

8

[Chemokines and chemokine receptors in multiple sclerosis].

Misu T, Fujihara K, Itoyama Y. Misu T, et al. Nihon Rinsho. 2003 Aug;61(8):1422-7. Nihon Rinsho. 2003. PMID: 12962033 Review. Japanese.

9

Interferon-alpha significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP.

Feng J, Misu T, Fujihara K, Saito H, Takahashi T, Kohnosu T, Shiga Y, Takeda A, Sato S, Takase S, Itoyama Y. Feng J, et al. Among authors: misu t. J Neuroimmunol. 2003 Aug;141(1-2):170-3. doi: 10.1016/s0165-5728(03)00219-4. J Neuroimmunol. 2003. PMID: 12965269

10

Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica.

Nakashima I, Fujihara K, Fujimori J, Narikawa K, Misu T, Itoyama Y. Nakashima I, et al. Among authors: misu t. Neurology. 2004 Jan 13;62(1):144-6. doi: 10.1212/wnl.62.1.144. Neurology. 2004. PMID: 14718720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters